The Gross Margin of Abionyx Pharma SA (ABNX.PA) is 18.35%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 18.35% |
| 2023-12-31 | 13.32% |
| 2022-12-31 | 12.11% |
| 2021-12-31 | 38.37% |